The combination of lifestyle interventions and disease-modifying drugs could be an interesting approach to preventing cognitive impairment. Disease-modifying drugs are known or repurposed drugs, including metformin. A link has been established between type 2 diabetes and Alzheimer's disease, with potential neuroprotective effects of metformin. In this international, randomized, controlled, double-blind, phase 2 clinical trial, 600 participants were recruited at 3 sites for a total study duration of 2 years. Metformin is administered in the form of 500 mg tablets.
Last press reviews
Effects of Cocoa Polyphenol-Rich Dark Chocolate on Brain Efficiency During Cognitive Tasks
Polyphenols found in cocoa, particularly in dark chocolate, are known for...
Dark Chocolate and Well-Being in Menopausal Women: A Study on Depression and Overall Health
Menopause is often associated with an increase in depressive symptoms, aff...
COVID-19 and coagulation parameters: a link to mortality?
The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...